Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Sell
36
HQY Quote, Financials, Valuation and Earnings
Last price:
$86.37
Seasonality move
:
5.33%
Day range:
$83.76 - $85.94
52-week range:
$74.07 - $116.65
Dividend yield:
0%
P/E ratio:
38.77x
P/S ratio:
5.77x
P/B ratio:
3.39x
Volume:
1.5M
Avg. volume:
1M
1-year change:
-19.24%
Market cap:
$7.2B
Revenue:
$1.2B
EPS (TTM):
$2.18
Analysts' Opinion
-
Consensus RatingHealthEquity, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 1 Hold rating, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $119.13, HealthEquity, Inc. has an estimated upside of 40.83% from its current price of $84.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $86.00 representing 100% downside risk from its current price of $84.59.
Fair Value
-
According to the consensus of 11 analysts, HealthEquity, Inc. has 40.83% upside to fair value with a price target of $119.13 per share.
HQY vs. S&P 500
-
Over the past 5 trading days, HealthEquity, Inc. has overperformed the S&P 500 by 1.31% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
HealthEquity, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HealthEquity, Inc. has grown year-over-year revenues for 18 quarters straight. In the most recent quarter HealthEquity, Inc. reported revenues of $322.2M.
Earnings Growth
-
HealthEquity, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter HealthEquity, Inc. reported earnings per share of $0.59.
Enterprise value:
7.9B
EV / Invested capital:
2.51x
Price / LTM sales:
5.77x
EV / EBIT:
24.33x
EV / Revenue:
6.16x
PEG ratio (5yr expected):
0.39x
EV / Free cash flow:
21.91x
Price / Operating cash flow:
20.54x
Enterprise value / EBITDA:
16.49x
Gross Profit (TTM):
$793.2M
Return On Assets:
5.56%
Net Income Margin (TTM):
14.86%
Return On Equity:
9.01%
Return On Invested Capital:
5.97%
Operating Margin:
24.79%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | $971M | $1.2B | $1.3B | $300.4M | $322.2M | |
| Gross Profit | $498.7M | $643.4M | $793.2M | $168.7M | $201.1M | |
| Operating Income | $105.3M | $199.7M | $326.6M | $54.1M | $79.9M | |
| EBITDA | $260.9M | $360.9M | $481.8M | $94.8M | $118.6M | |
| Diluted EPS | $0.34 | $1.10 | $2.18 | $0.06 | $0.59 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $764.1M | $332.2M | $474.4M | $495.2M | $498.7M | |
| Total Assets | $3.1B | $3.1B | $3.1B | $3.5B | $3.4B | |
| Current Liabilities | $107.1M | $110.4M | $96.2M | $154.5M | $120.6M | |
| Total Liabilities | $1.2B | $1.2B | $1.1B | $1.4B | $1.3B | |
| Total Equity | $1.9B | $1.9B | $2B | $2.1B | $2.1B | |
| Total Debt | $997.9M | $987.5M | $924.9M | $1.1B | $1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $221.2M | $341.2M | $414.9M | $90.6M | $138.6M | |
| Cash From Investing | -$45.1M | -$503.2M | -$52.3M | -$12.9M | -$11.4M | |
| Cash From Financing | -$52.3M | $150.1M | -$375.6M | -$82.4M | -$122.4M | |
| Free Cash Flow | $176.2M | -$162M | $362.7M | $77.7M | $127.2M | |
HQY
Sector
Market Cap
$7.2B
$25.9M
Price % of 52-Week High
72.52%
51.02%
Dividend Yield
0%
0%
Shareholder Yield
3.67%
-1.66%
1-Year Price Total Return
-19.24%
-18.63%
Beta (5-Year)
0.201
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$86.19
200-day SMA
Sell
Level
$94.63
Bollinger Bands (100)
Sell
Level
89.75 - 98.97
Chaikin Money Flow
Buy
Level
67.2M
20-day SMA
Sell
Level
$90.97
Relative Strength Index (RSI14)
Sell
Level
35.10
ADX Line
Sell
Level
17.77
Williams %R
Buy
Level
-88.9618
50-day SMA
Sell
Level
$95.67
MACD (12, 26)
Sell
Level
-3.02
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
115.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.7561)
Buy
CA Score
(Annual)
Level (0.4937)
Buy
Beneish M-Score
(Annual)
Level (-2.7443)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.1858)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.
Stock Forecast FAQ
In the current month, HQY has received 9 Buy ratings 1 Hold ratings, and 1 Sell ratings. The HQY average analyst price target in the past 3 months is $119.13.
-
Where Will HealthEquity, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that HealthEquity, Inc. share price will rise to $119.13 per share over the next 12 months.
-
What Do Analysts Say About HealthEquity, Inc.?
Analysts are divided on their view about HealthEquity, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthEquity, Inc. is a Sell and believe this share price will drop from its current level to $86.00.
-
What Is HealthEquity, Inc.'s Price Target?
The price target for HealthEquity, Inc. over the next 1-year time period is forecast to be $119.13 according to 11 Wall Street analysts, 9 of them rate the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HQY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HealthEquity, Inc. is a Buy. 9 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HQY?
You can purchase shares of HealthEquity, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthEquity, Inc. shares.
-
What Is The HealthEquity, Inc. Share Price Today?
HealthEquity, Inc. was last trading at $86.37 per share. This represents the most recent stock quote for HealthEquity, Inc.. Yesterday, HealthEquity, Inc. closed at $84.59 per share.
-
How To Buy HealthEquity, Inc. Stock Online?
In order to purchase HealthEquity, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HQY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HQY
Sector
P/E ratio
38.77x
23.89x
PEG ratio
0.39x
-0.01x
P/B ratio
3.39x
1.81x
Price / LTM sales
5.77x
1.57x
Growth Metrics
HQY
Sector
Revenue growth
7.23%
4.24%
Earnings growth
824.42%
9.72%
Revenue (5-year growth)
17.66%
6.32%
Earnings forecast
$0.91
-$0.18
Profitability
HQY
Sector
Profitability FY 2024
$692.6M
$3.1M
Return on invested capital
5.97%
-32.89%
Return on assets
5.56%
-29.56%
Return on equity
9.01%
-38.65%
Earnings Date
Last Earnings Date
Dec
3
Next Earnings Date
Mar
17
Estimated Next Earnings Date
Mar
4
Balance Sheet
HQY
Sector
Total cash
$309.3M
$25.2M
Short term investments
--
$25.1M
Total assets
$3.5B
$73.4M
Long term debt
$1B
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Sell
27
RGC alert for Jan 22
Regencell Bioscience Holdings Ltd. [RGC] is up 40.39% over the past day.
Buy
62
BNR alert for Jan 22
Burning Rock Biotech Ltd. [BNR] is up 33.29% over the past day.
Buy
71
HYMC alert for Jan 22
Hycroft Mining Holding Corp. [HYMC] is up 17.39% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
